Digital innovation and proactive patient care are converging to transform clinical practice while preserving essential safeguards.
|Articles|October 10, 2022
Live Now: Drug Topics® Annual Salary Survey
Readers, we want to hear from you.
Advertisement
Last year, over 1100 pharmacists and pharmacy professionals participated in the Drug Topics® Annual Salary Survey. Each year, the Salary Survey gives our readers the opportunity to share their feelings on important workplace issues.
Your experience matters:
Advertisement
Related to this article
As pouched products increase in popularity, researchers assess their pharmacology, harm-reduction potential, and initiation risk.
In part 2, Vanessa Slowey explains the pharmacy industry’s need for due diligence as technology reinforces patient convenience in the 21st century.
In this episode, Shawn Bjorndal, PharmD, RPh, and Jesse McCullough, PharmD, explore rhythms, routines and how they can make or break pharmacy team members.
Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what innovations are still expected.
Researchers assess the neurological outcomes of over 200,000 children exposed to COVID-19 before birth.
Results show consistent improvements in wakefulness, cataplexy, and quality of life with oveporexton for patients with narcolepsy.
Researchers assess the differences in out-of-pocket spending on brand name compared with generic medication.
Advertisement
Advertisement
Trending on Drug Topics
1
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
2
Study Finds No Neurodevelopmental Risk in Prenatal COVID-19, Except Speech
3
Oveporexton Met Primary, Key Secondary End Points in Phase 3 Studies
4
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
5